Position in BEAM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,212,557
-$908,793 QoQ
Shares Held
93,606
-45.9% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 274 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. BEAM ranks #31 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in BEAM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,212,557 | 93,606 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,121,350 | 172,948 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,902,531 | 176,859 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,328,679 | 137,152 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,089,372 | 122,832 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,341,080 | 119,871 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,755,280 | 111,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,583,729 | 187,091 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,872,135 | 165,264 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,073,456 | 244,354 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,247,096 | 339,717 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,180,391 | 340,141 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,237,652 | 257,991 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,481,274 | 211,668 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,615,694 | 194,725 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,903,787 | 123,925 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,682,864 | 120,973 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,178,945 | 90,383 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,879,448 | 73,779 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,489,008 | 28,606 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,782,786 | 29,390 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,709,674 | 33,854 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $883,753 | 10,825 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||